ProfileGDS4459 / ENSG00000137817
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 67% 66% 86% 50% 83% 72% 75% 79% 76% 77% 68% 78% 78% 67% 81% 69% 62% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 15.0967
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 2566
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 36.8286
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 44.4950
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 56.583
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 65.4372
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 75.875
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 86.0879
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 95.976
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 105.9377
GSM623474group B, liver allograft wedge biopsie placebo treatment 15.1268
GSM623475group B, liver allograft wedge biopsie placebo treatment 26.0578
GSM623476group B, liver allograft wedge biopsie placebo treatment 35.9178
GSM623477group B, liver allograft wedge biopsie placebo treatment 45.0267
GSM623478group B, liver allograft wedge biopsie placebo treatment 56.3681
GSM623479group B, liver allograft wedge biopsie placebo treatment 65.1169
GSM623480group B, liver allograft wedge biopsie placebo treatment 74.8162